Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Contraceptive pills which are a kind of female hormonal anti-conception medication technique and are extremely viable at avoiding pregnancy. Birth control pills stop the ovaries from releasing eggs and thickens the cervical mucus, which keeps sperm from fertilizing the egg. Birth control pills come in two forms a combination pills contain two hormones, progestin and estrogen, while the “mini-pills” contain only progestin. Generally, combination birth control pills are slightly more effective than progestin-only birth control pills.
The growth of the global contraceptives market is attributed to the rising incidences of unwanted pregnancies coupled with the growing prevalence of sexually transmitted diseases, increasing need of population control and increasing incident of abortion has driven the growth of the market. As per Avert Organisation data, HIV continues to be a major global public health issue. In 2017 an estimated 36.9 million people were living with HIV (including 1.8 million children) with a global HIV prevalence of 0.8% among adults. In 2017, 940,000 people deaths occurred due to AIDS-related illnesses. The vast majority of people living with HIV are located in low- and middle- income countries.
Furthermore, government and non-government organizations are funding and supporting programs to encourage contraception. Huge unexplored contraceptives market in developing economies is generating plenty opportunities for the global contraceptives market to grow at a considerable rate in the coming years. Several major players in the contraception market are actively involved in the research and new product development for contraception, which could meet the demand of cost-effective long-term contraception.
The report analyses the Contraceptive Pills Market by hormone type, age group, category and geography.
Based on Hormone type, the market is classified into Progestin Pills, Combination Pills and Emergency Pills. Combination pills are sub classified into Monophasic, Triphasic and other pills. Combination pills are pegged to hold significant market share on global revenues. Combination pills are effective in reducing the risks of ovarian cancer, ectopic pregnancy, as well as the incidence of iron deficiencies in a state of premenstrual tension.
Based on age group usage, the market is segmented into age group of females under 24 years, between 24 - 35 years and above 36 years.
From menarche to menopause, women choose different methods of contraception for many different reasons including convenience, expense, availability, benefits, sexual intentions, attitudes and the maturity of the contraceptive user. It is observed that contraceptive pills method, particularly the combined oral contraceptive pill, are a viable choice for young women from menarche age to 35 years.
On the basis of Category, the market is bifurcated into generic oral contraceptive pills and branded pills. The generic oral contraceptive pills held the significant market share of the revenue and is expected to observe the lucrative growth during the forecast period owing to the widespread adoption of generic contraceptives facilitated by their low prices and ease of use.
Geographically Contraceptive Pills Market is studies across North America, Europe, APAC & Rest of the world. North America led the global contraceptive pills market, primarily attributed to a greater incidence of unintended pregnancies in the region.
As per Guttmacher Institute study, the unintended pregnancy rate is significantly higher in the United States than in many other developed countries. In 2011, nearly half (45%, or 2.8 million) of the 6.1 million pregnancies in the United States were unintended. This indicates the high awareness and demand for avoiding unintended pregnancies in the United States.
Asia Pacific is observed as one of the most attractive market for oral contraceptive pills in the course of the forecast period owing to the stable economic development in major countries including Singapore, India, China, Australia, and Philippines. This economic growth in turn has resulted in the growing disposable income of the people, growing awareness about family planning and contraceptives, and the desire for healthier living. This, in turn, has led to the rising adoption rate of oral contraceptive pills in the region.
Major Players involved in the market are Agile Therapeutics, Bayer Healthcare, Church & Dwight Co., Inc., Johnson & Johnson Ltd, Lupin Pharmaceuticals Ltd, Merck & Co., Mylan Laboratories, Novartis, Pfizer and Teva Pharmaceuticals Ltd, among others.
The report analyses the global Contraceptive Pills Market on the basis of hormone type age group, category and geography.
Based on Hormone type, the market is classified into Progestin Pills, Combination Pills and Emergency Pills. Combination pills are sub classified into Monophasic, Triphasic and other pills. Based upon age group usage, the market is categorised into age group of females under 24 years, between 24 - 35 years and above 36 years. Further, on the basis of Category, the market is bifurcated into generic oral contraceptive pills and branded pills. Geographically Contraceptive Pills Market is studies across North America, Europe, APAC & Rest of the world.
Some of the leading players operating in the global Contraceptive Pills Market are Agile Therapeutics, Bayer Healthcare, Church & Dwight Co., Inc., Johnson & Johnson Ltd, Lupin Pharmaceuticals Ltd, Merck & Co., Mylan Laboratories, Novartis, Pfizer and Teva Pharmaceuticals Ltd, among others.
Why to buy this report:
GET CUSTOMIZED MARKET DATA